NATISPRAY 0.15 mg/dose, solution as an oromucosal spray 200 doses
Active ingredients: Nitroglycerin, TRINITRINE (SOLUTION DE)
Commercialized according to BDPMDispensing in France: Prescription only
Solution for spraying200 dosessublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NATISPRAY 0,15 mg/dose, solution pour pulvérisation buccale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- sublinguale
- Presentation description
- 1 flacon(s) aluminium verni de 200 dose(s) avec pompe(s) doseuse(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1988
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60259242CIP73293698CIP133400932936984Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRINITRINEsolution | 0,150000 mg · une dose de 0,05 ml | FT |
| TRINITRINE (SOLUTION DE)solution | 0,004580 ml de solution à 4 % · une dose de 0,05 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.